Literature DB >> 19719807

Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.

J S P van den Berg1, G de Jong.   

Abstract

OBJECTIVES: To determine the proportion of patients with an ischemic stroke that received intravenous (IV) thrombolytic treatment, and reasons why patients are not treated.
METHODS: A prospective registry of all patients with an ischemic stroke admitted to our emergency department (ED).
RESULTS: A total of 286 patients with an ischemic stroke were admitted. Eighty-one patients were admitted within 3 h of onset of neurological deficit, of which 28 received IV thrombolysis. In 25 patients no thrombolytic treatment was given because of the presence of the National Institute of Neurological Disorders and Stroke (NINDS) exclusion criteria, and one patient refused treatment. No thrombolytic treatment was given to 27 patients because of mild neurological deficit or rapid clinical improvement, and after 3 months all these patients were independently living at home without nursing help. Despite a public campaign to gain awareness concerning stroke, the majority of the patients arrived too late at the ED for thrombolytic treatment.
CONCLUSIONS: A large proportion of the patients with an ischemic stroke are admitted too late to receive IV thrombolysis. More needs to be done to increase both public and medical awareness of stroke as a treatable emergency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719807     DOI: 10.1111/j.1600-0404.2008.01140.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

Review 1.  Safety and Efficacy of Mechanical Thrombectomy Using Stent Retrievers in the Endovascular Treatment of Acute Ischaemic Stroke: A Systematic Review.

Authors:  Janet Puñal-Riobóo; Gerardo Atienza; Miguel Blanco
Journal:  Interv Neurol       Date:  2015-07

2.  Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke.

Authors:  Pooja Khatri; Mark R Conaway; Karen C Johnston
Journal:  Stroke       Date:  2011-11-03       Impact factor: 7.914

3.  Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms.

Authors:  Joshua Z Willey; Joshua Stillman; Juan A Rivolta; Julio Vieira; Margaret M Doyle; Guillermo Linares; Adrian Marchidann; Mitchell S V Elkind; Bernadette Boden-Albala; Randolph S Marshall
Journal:  Int J Stroke       Date:  2011-11-22       Impact factor: 5.266

Review 4.  Randomized trials of endovascular therapy for stroke--impact on stroke care.

Authors:  Maxim Mokin; Haydy Rojas; Elad I Levy
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

5.  Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network.

Authors:  Joshua Z Willey; Pooja Khatri; Jane C Khoury; José G Merino; Andria L Ford; Natalia S Rost; Nicole R Gonzales; Latisha K Ali; Brett C Meyer; Joseph P Broderick
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-15       Impact factor: 2.136

6.  Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.

Authors:  Peter Kraft; Tobias Schwarz; Joost C M Meijers; Guido Stoll; Christoph Kleinschnitz
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

7.  Ethnicity and thrombolysis in ischemic stroke: a hospital based study in Amsterdam.

Authors:  Jonathan M Coutinho; Eva C Klaver; Yvo B Roos; Jan Stam; Paul J Nederkoorn
Journal:  BMC Neurol       Date:  2011-06-30       Impact factor: 2.474

8.  Discovery of 3-n-butyl-2,3-dihydro-1H-isoindol-1-one as a potential anti-ischemic stroke agent.

Authors:  Zujian Lan; Xiaoyu Xu; Wenkai Xu; Jin Li; Zengrong Liang; Xuefei Zhang; Ming Lei; Chunshun Zhao
Journal:  Drug Des Devel Ther       Date:  2015-06-30       Impact factor: 4.162

9.  Factors influencing nonadministration of thrombolytic therapy in early arrival strokes in a university hospital in Hyderabad, India.

Authors:  Lalitha Pidaparthi; Anitha Kotha; Venkat Reddy Aleti; Abhijeet Kumar Kohat; Mridula R Kandadai; Suryaprabha Turaga; Jabeen A Shaik; Suvarna Alladi; Meena A Kanikannan; Borgohain Rupam; Subhash Kaul
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

10.  Progression of stroke deficits in patients presenting with mild symptoms: The underlying etiology determines outcome.

Authors:  Naveed Akhtar; Saadat Kamran; Hisham Elkhider; Soha Al-Makki; Noha Mhjob; Lubna ElShiekh; Hassan AlHussain; Musab Ali; Rola Khodair; Faisal Wadiwala; Abdul Salam; Dirk Deleu; Reny Francis; Ashfaq Shuaib
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.